Innoviva
INVA
#5088
Rank
S$2.03 B
Marketcap
S$27.25
Share price
1.25%
Change (1 day)
5.98%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): S$0.20 Billion

According to Innoviva's latest financial reports the company's current earnings are S$0.38 Billion. In 2024 the company made an earning of S$48.51 Million a decrease over its 2023 earnings that were of S$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.20 B312.66%
2024 S$48.51 M-80.74%
2023 S$0.25 B-32.36%
2022 S$0.37 B-35.56%
2021 S$0.57 B25.7%
2020 S$0.45 B52.11%
2019 S$0.30 B10.77%
2018 S$0.27 B56.59%
2017 S$0.17 B125.53%
2016 S$77.24 M-417.36%
2015 -S$24.35 Million-74.49%
2014 -S$95.41 Million-25.19%
2013 -S$0.13 Billion430.06%
2012 -S$24.06 Million-83.92%
2011 -S$0.15 Billion39.82%
2010 -S$0.11 Billion2.84%
2009 -S$0.11 Billion-8.62%
2008 -S$0.12 Billion-47.92%
2007 -S$0.22 Billion-5.92%
2006 -S$0.24 Billion19.8%
2005 -S$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-S$23.56 Million-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-S$0.21 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA